Norstella

We provide actionable answers from pre-clinical to post-launch. What can Norstella help you with? https://ow.ly/acO550PQWIE #Pipeline2Patient #Answers4Pharma #Pharma Citeline, Evaluate Ltd, MMIT (Managed Markets Insight & Technology), Panalgo, The Dedham Group

As drug discovery becomes more complex, companies must innovate to stay ahead. https://ow.ly/JIKt50SxnJ7 Norstella is using AI to help biopharma professionals better understand challenges and guide decisions to improve pipeline to patient decision-making.

Explore the forefront of pharmaceutical innovation with Norstella’s June roundup, featuring cutting-edge insights from industry trailblazers and learn about the latest news and updates from our brands. Check out the links below. 👇 Norstella announced a new strategic partnership with Atropos Health, the pioneer in translating real-world clinical data into high-quality, personalized, real-world evidence for care. Read about the benefits for Panalgo and Citeline customers: https://ow.ly/PgZO50SsStC Citeline Regulatory's TrialScope Disclose has been the leader in helping clinical trial sponsors prepare their studies for public disclosure for over a decade. With the addition of the Core Data platform, it continues to provide cutting-edge disclosure technology to enable seamless regulatory compliance. Learn more: https://ow.ly/uvA750SsStG Are you ready to look at the pharma landscape through a long-range lens? Evaluate Ltd has just released new forecasts out to 2030. Register for the World Preview Webinar 2024 Pharma’s Growth Boost: https://ow.ly/Sylo50SsStF Do you need a primer on market access? In this free ebook from MMIT (Managed Markets Insight & Technology) for pharma, you can learn how to understand and influence payer policies, improve coverage and communicate with HCPs. https://ow.ly/eSgf50SsStJ Understanding open and closed claims is critical. In this eBook, Panalgo's Executive Director of Solutions, Margaret (Meg) Richards, PhD, MPH, uncovers the nuances of open vs. closed claims: https://ow.ly/jP8v50SsStI The Dedham Group stands as the premier pharmaceutical consultancy firm, renowned for its expertise in crafting, executing, and overseeing Patient Support Programs. Learn about The Dedham Group’s customized solutions that drive success: https://ow.ly/c20450SsStE Follow our brands to stay up with the latest news, insights, and updates! #Pipeline2Patient #FollowNorstella

Pharma and biotech companies, including small biopharmas, are increasingly partnering with contract development and manufacturing organizations (CDMOs) to outsource drug development. https://ow.ly/HL6F50SvXGO Why are small biopharmas outsourcing more? Click to read the article to see the results of a recent Citeline survey to learn why pharma companies of all sizes might choose end-to-end CDMO partnerships. #Pharma #Biopharma #CDMOs

Norstella held a roundtable discussion in London, and we put all the insights from our executive leadership team in one document. Download the "Putting the patient first" report: https://ow.ly/EKq550SlZin The executive leadership team included: Maureen Ladouceur, EVP and Chief Commercial Officer Andy Augustine, Chief Technology Officer Thomas Halliday, General Manager, Strategic Intelligence Moderated by Barnaby Pickering, Managing Editor, Custom Content Download and read the full report today! #Pipeline2Patient #FollowNorstella

✨ The Dedham Group are looking to hire a HR Director who will provide specialist support as they continue to expand at pace ✨ This is a newly created, hybrid position and we are looking for a strategic HR professional who: 📈 Can deliver effective HR and engagement strategies which support the team to deliver on business objectives 🚀 Has experience working in a high performance & high engagement start-up/scale-up environment 🌞 Is an action-orientated individual who is able to work collaboratively in a cross-functional organisation If this sounds like your perfect role, please click on the link below for more information or get in touch if you have any questions! #HR #employeeengagement #Consulting #TheDedhamGroup

Our mission is to help patients access life-saving therapies by transforming the drug development journey. Download the "Putting the patient first" report from our leadership roundtable: https://ow.ly/94MP50SpvvE

Explore the forefront of pharmaceutical innovation with Norstella’s June roundup, featuring cutting-edge insights from industry trailblazers and learn about the latest news and updates from our brands. Check out the links below. 👇 Norstella announced a new strategic partnership with Atropos Health, the pioneer in translating real-world clinical data into high-quality, personalized, real-world evidence for care. Read about the benefits for Panalgo and Citeline customers: https://ow.ly/Ouay50Ss452 Citeline Regulatory's TrialScope Disclose has been the leader in helping clinical trial sponsors prepare their studies for public disclosure for over a decade. With the addition of the Core Data platform, it continues to provide cutting-edge disclosure technology to enable seamless regulatory compliance. Learn more: https://ow.ly/LZSq50Ss44Z Are you ready to look at the pharma landscape through a long-range lens? Evaluate Ltd has just released new forecasts out to 2030. Register for the World Preview Webinar 2024 Pharma’s Growth Boost: https://ow.ly/V6Jm50Ss450 Do you need a primer on market access? In this free ebook from MMIT (Managed Markets Insight & Technology) for pharma, you can learn how to understand and influence payer policies, improve coverage and communicate with HCPs. https://ow.ly/XKEN50Ss45i Understanding open and closed claims is critical. In this eBook, Panalgo's Executive Director of Solutions, Margaret (Meg) Richards, PhD, MPH, uncovers the nuances of open vs. closed claims: https://ow.ly/7I0k50Ss459 The Dedham Group stands as the premier pharmaceutical consultancy firm, renowned for its expertise in crafting, executing, and overseeing Patient Support Programs. Learn about The Dedham Group’s customized solutions that drive success: https://ow.ly/y1FG50Ss457 Follow our brands to stay up with the latest news, insights, and updates! #Pipeline2Patient #FollowNorstella

In our blog post, Daniel Chancellor suggests that rather than becoming more risk-averse, drug developers should seek to shift attrition to the earliest stages of development. This allows for prioritization of the best assets with the most significant patient impact. Click to read about why clinical development success rates are falling on the Norstella blog: https://ow.ly/RB4950RIN9C. #ClinicalDevelopment #DrugDevelopment #Biopharma #BiopharmaceuticalCompanies #BiopharmaTrends

Welcome, Norstella 2024 interns! We're excited to learn from you as much as we hope you learn from us this summer! Discover how our internship program plans to guide this year's diverse and eager group of professionals by watching the yearbook video here: https://ow.ly/Gcio50SqTJy #Pipeline2Patient #FollowNorstella